Form D Explorer
PLEOPHARMA, INC. · CIK 1801323

Report a data issueCitable research briefCompare issuerPrivate research collection

PLEOPHARMA, INC.

CIK 1801323 · Corporation · Inc. DELAWARE · PHOENIXVILLE, Pennsylvania · Pharmaceuticals

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Aug 8, 2025
through Aug 10, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldAug 8, 2025 · DAug 10, 2026 · DLater minus earlier
Reported offering amount$36,240,000$15,000,000$-21,240,000
Reported amount sold$6,150,000$5,500,000$-650,000
Reported investor count—11—
Reported minimum investment$50,000$50,000$0

Earlier SEC source: 0001801323-25-000003 · Later SEC source: 0001801323-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Aug 10, 2026

Reported offering amount
$15,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$5,500,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Same reported sales compensation recipient

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (2)